Rheumatoid Arthritis Clinical Trials in New York

Showing 1001-1020 of 3,596 trials

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

NCT03603808

This phase II trial studies the use of human papillomavirus (HPV) deoxyribonucleic acid (DNA) plasmids therapeutic vaccine VGX-3100 (VGX-3100) and electroporation in treating patients with human immunodeficiency virus (HIV)-positive high-grade anal lesions. Vaccines made from DNA may help the body build an effective immune response to kill tumor cells. Electroporation helps pores in your body's cells take in the drug to strengthen your immune system's response. Giving VGX-3100 and electroporation together may work better in treating patients with high-grade anal lesions.

Anal Intraepithelial NeoplasiaHigh Grade Squamous Intraepithelial NeoplasiaHIV Positivity+2 more

AIDS Malignancy Consortium35 participantsStarted Sep 2018

San Francisco, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +5 more locations

Active Not Recruiting< 1 mile

Long Term Follow Up for CTSN Mitral Valve Repair Studies

NCT03066050

This study is a continuation of two previous studies --- the Severe Ischemic Mitral Regurgitation (SMR) Trial (NCT00807040) and the Moderate Ischemic Mitral regurgitation (MMR) Trial (NCT00806988) --- to learn more about patients' health 5-10 years after their mitral valve surgeries. The investigators will collect long-term health information on SMR and MMR trial participants using electronic medical records, patient and/or family input, public records, and healthcare- and vital status-related databases.

Mitral Valve InsufficiencyCoronary Artery Disease

Icahn School of Medicine at Mount Sinai368 participantsStarted May 2017

Los Angeles, California, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +21 more locations

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Long Term Follow Up for CTSN Mitral Valve Repair Studies

Rheumatoid Arthritis Trials in Other Cities

MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM

MitraClip EXPAND G4 Study

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

RNS System NAUTILUS Study

Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Circumferential Vertebral Reconstruction of Osteoporotic Compression Fractures Using a Novel Bipedicular Peek Implant

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

The Life STORRIED Study

Paracervical Block for Pain Reduction in Saline Infusion Sonograms

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)

Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis

Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Other Conditions in New York